3 completed, 1 unknown. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Unknown 1 |
| Phase 2 | 2 | Completed 2 |
Follow PCV13: new trials by email Literature Review of PCV13 trials Research Report on PCV13
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I Clinical Trial of a Candidate PCV13 in Healthy People 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine - Pneumococcal Infections | Phase 1 | Unknown | Wuhan BravoVax Co., Ltd. | 264 | 2022-11-01 | 2022-11-17 |
| A Study to Assess the Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active Comparator ASP3772, PCV13 - Healthy Volunteers, Pneumococcal Disease | Phase 1 | Completed | Affinivax, Inc. | 75 | 2020-09-22 | 2022-06-06 |
| A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal Vaccine ASP3772, PCV13, PPSV23 - Pneumonia, Bacterial, Healthy Volunteers | Phase 1 / Phase 2 | Completed | GlaxoSmithKline | 630 | 2019-01-24 | 2023-12-21 |
| Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma MILs, Melphalan, PCV13 - Multiple Myeloma and Plasma Cell Neoplasm | Phase 1 / Phase 2 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 26 | 2007-11-01 | 2023-05-26 |
Pneumococcal Infections (3) · Multiple Myeloma (1) · Neoplasms, Plasma Cell (1) · Pneumonia, Bacterial (1) · Pneumonia, Pneumococcal (1)
Affinivax, Inc. (1) · GlaxoSmithKline (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · Wuhan BravoVax Co., Ltd. (1)
United States (3) · China (1)
PMID 25995224, PMID 35690500, PMID 38360475
2019 (1), P30CA006973 (1)